Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

被引:9
|
作者
Xu, Hongen [1 ]
You, Guangxian [2 ]
Zhang, Minjun [1 ,3 ]
Song, Tao [1 ]
Zhang, Haibo [1 ]
Yang, Jia [1 ]
Jia, Yongshi [1 ]
Tang, Jianming [1 ]
Liang, Xiaodong [1 ]
机构
[1] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Dept Radiat Oncol, Canc Ctr,Peoples Hosp, 158 Shangtang Rd, Hangzhou 310014, Zhejiang, Peoples R China
[2] Taizhou Canc Hosp, Dept Radiat Oncol, Taizhou 317502, Peoples R China
[3] Bengbu Med Coll, Grad Dept, 2600 Donghai Ave, Bengbu 233000, Peoples R China
关键词
Rectal cancer; Lymphocyte counts; Disease-free survival; Chemoradiotherapy; ACUTE HEMATOLOGIC TOXICITY; DOSIMETRIC PARAMETERS; CERVICAL-CANCER; LYMPHOPENIA; CHEMORADIATION; CHEMOTHERAPY; PREDICTORS; MARKER; TUMOR;
D O I
10.1186/s12957-019-1747-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Colorectal cancer is the fourth most common cancer globally and neoadjuvant concurrent chemoradiotherapy (nCRT) and surgery are the standard treatments for locally advanced colorectal carcinoma. This study investigated the association between dynamic changes in absolute lymphocyte counts (ALCs) and disease-free survival (DFS) in rectal cancer patients receiving nCRT and identified factors associated with these changes. Methods We retrospectively examined 34 patients with locally advanced rectal cancer who received nCRT followed by surgery and adjuvant chemotherapy. The association between ALCs and DFS and that between ALCs and downstaging were analyzed and potential clinical- and treatment-related factors related to dynamic changes in ALCs were subsequently evaluated. The patient eligibility criteria were as follows: pathologically confirmed rectal adenocarcinoma, clinical stages II-III, >= 18 years of age, and so on. Pre-RTL was defined as ALCs obtained before the initiation of nCRT and pre-SL was defined as ALCs obtained before surgery. We measured pre-SL to pre-RTL ratio (pre-SLR), DFS, and ALCs. Results The median ALC declined significantly during nCRT. A lower pre-SLR was associated with poorer DFS with statistical significance in Kaplan-Meier (p = 0.007), univariate regression (hazard ratio [HR] = 6.287, 95% confidence interval [CI] 1.374-28.781, p = 0.018), and multivariable regression (HR = 7.347, 95% CI 1.595-33.850, p = 0.011) analyses. Neither patient characteristics nor treatment-related factors were related to downstaging. The pelvic bone marrow (PBM) volume receiving at least 30 Gy (V30) was significantly associated with pre-SLR in the univariate (HR = 5.760, 95% CI 1.317-25.187, p = 0.020) and multivariable (HR = 5.760, 95% CI 1.317-25.187, p = 0.020) regression analyses. Limitations Our study had several limitations. The sample size was small and the study was performed in a selected population, which may limit the generalization of the findings. Conclusions Radiotherapy had a profound impact on the change in ALCs. A lower pre-SLR was significantly associated with poorer DFS in rectal cancer patients receiving nCRT. The V30 of PBM was a predictor of pre-SLR.
引用
收藏
页数:7
相关论文
共 35 条
  • [21] Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis
    Lee, Joo Hwan
    Jeong, Jae Uk
    Kim, Sung Hwan
    Nam, Taek Keun
    Lee, Jong Hoon
    Jeong, Songmi
    Yu, Mina
    Jang, Hong Seok
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (01) : 105 - 112
  • [22] MRI Assessment of Extramural Venous Invasion Before and After Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer and Its Association with Disease-Free and Overall Survival
    Thompson, Hannah M. M.
    Bates, David D. B.
    Pernicka, Jennifer Golia
    Park, Sun Jin
    Nourbakhsh, Mahra
    Fuqua, James L. L.
    Fiasconaro, Megan
    Lavery, Jessica A. A.
    Wei, Iris H. H.
    Pappou, Emmanouil P. P.
    Smith, J. Joshua
    Nash, Garrett M. M.
    Weiser, Martin R. R.
    Paty, Philip B. B.
    Garcia-Aguilar, Julio
    Widmar, Maria
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (07) : 3957 - 3965
  • [23] The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study
    Tsai, Hsiang-Lin
    Yeh, Yung-Sung
    Chen, Po-Jung
    Chang, Yu-Tang
    Chen, Yen-Cheng
    Su, Wei-Chih
    Chang, Tsung-Kun
    Huang, Ching-Wen
    Wang, Jaw-Yuan
    INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [24] Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery
    Chen, Chen
    Yi, Wei
    Zeng, Zhi-fan
    Wang, Qiao-xuan
    Jiang, Wu
    Gao, Yuan-hong
    Chang, Hui
    BMC CANCER, 2022, 22 (01)
  • [25] Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery
    Chen Chen
    Wei Yi
    Zhi-fan Zeng
    Qiao-xuan Wang
    Wu Jiang
    Yuan-hong Gao
    Hui Chang
    BMC Cancer, 22
  • [26] Pre-treatment hormonal receptor status and Ki67 index predict pathologic complete response to neoadjuvant trastuzumab/taxanes but not disease-free survival in HER2-positive breast cancer patients
    Zhang, Guo-Chun
    Qian, Xue-Ke
    Guo, Zi-Bai
    Ren, Chong-Yang
    Yao, Meng
    Li, Xue-Rui
    Wang, Kun
    Zu, Jian
    Liao, Ning
    MEDICAL ONCOLOGY, 2012, 29 (05) : 3222 - 3231
  • [27] Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy
    Pickles, Martin D.
    Manton, David J.
    Lowry, Martin
    Turnbull, Lindsay W.
    EUROPEAN JOURNAL OF RADIOLOGY, 2009, 71 (03) : 498 - 505
  • [28] Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis
    Joo Hwan Lee
    Jae Uk Jeong
    Sung Hwan Kim
    Taek Keun Nam
    Jong Hoon Lee
    Songmi Jeong
    Mina Yu
    Hong Seok Jang
    International Journal of Colorectal Disease, 2019, 34 : 105 - 112
  • [29] NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival
    Voboril, R.
    Rychterova, V.
    Voborilova, J.
    Kubecova, M.
    Fanta, J.
    Dvorak, J.
    NEOPLASMA, 2016, 63 (03) : 462 - 470
  • [30] An Interval >7 Weeks between Neoadjuvant Therapy and Surgery Improves Pathologic Complete Response and Disease–Free Survival in Patients with Locally Advanced Rectal Cancer
    Hagit Tulchinsky
    Einat Shmueli
    Arie Figer
    Joseph M. Klausner
    Micha Rabau
    Annals of Surgical Oncology, 2008, 15 : 2661 - 2667